JUBLPHARMA · NSE
Not in active coverage. Cited reporting has mentioned Jubilant Pharmova, the record of those mentions is below. Your interest is logged; coverage expands by demand.
Jubilant Pharmova's share saw a significant action this week, with a gain of approximately 11%.
Jubilant Pharmova's step-down subsidiary Jubilant HollisterStier's Spokane contract manufacturing facility received a Voluntary Action Indicated (VAI) classification from the US FDA following an inspection in June 2026.
Jubilant Pharmova's contract manufacturing organisation facility in Spokane, Washington, has been classified as "Voluntary Action Indicated" by the US Food and Drug Administration.
This page lists where cited reporting has mentioned Jubilant Pharmova. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.